Autolus Therapeutics plc (AUTL)
NASDAQ·Healthcare·Biotechnology
$1.58
+0.96%
Mkt Cap $431.15M
Analyst Ratings
No recent rating data.
Price Target (4 analysts)
$8.87
Range $7.60 – $11.00
Implied Upside
+463.2%
Consensus $8.87 vs current $1.58
NASDAQ·Healthcare·Biotechnology
$1.58
+0.96%
Mkt Cap $431.15M
No recent rating data.
Price Target (4 analysts)
$8.87
Range $7.60 – $11.00
+463.2%
Consensus $8.87 vs current $1.58